114800.KS KODEX Biotechnology ETF Loading...

Loading chart...
Top Calls
Feed
Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
02:38
Jul 08
Park Ji-hoon Director, Asset Management Consulting Dept., NH Investment … 3PRO TV (삼프로TV)
Korean biotech ETF to converge with XBI.
A striking divergence has opened: the US XBI biotech ETF is hitting new highs (+32% YTD) while the Korean KODEX Biotech ETF is down -30%. Historically the two have very tight correlation with only a time lag. With the macro environment not hostile to growth stocks (Powell likely holding rates until September, no immediate inflation or employment fears), there is a strong case for Korean biotech to converge upward toward its US counterpart.
114800.KS 1ST
MED

About 114800.KS Analyst Coverage

Buzzberg tracks 114800.KS (KODEX Biotechnology ETF) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked. Past 7 days: 1 bullish. Latest voices: Park Ji-hoon.